Literature DB >> 22258604

Cancer: Reprogramming clinical outcome.

Geneviève Deblois, Vincent Giguère.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22258604     DOI： 10.1038/481275a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding.

Authors:  Simon C Biddie; Sam John; Pete J Sabo; Robert E Thurman; Thomas A Johnson; R Louis Schiltz; Tina B Miranda; Myong-Hee Sung; Saskia Trump; Stafford L Lightman; Charles Vinson; John A Stamatoyannopoulos; Gordon L Hager
Journal:  Mol Cell       Date:  2011-07-08       Impact factor: 17.970

2.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.

Authors:  Josée Laganière; Geneviève Deblois; Céline Lefebvre; Alain R Bataille; François Robert; Vincent Giguère
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

3.  Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Authors:  Jason S Carroll; X Shirley Liu; Alexander S Brodsky; Wei Li; Clifford A Meyer; Anna J Szary; Jerome Eeckhoute; Wenlin Shao; Eli V Hestermann; Timothy R Geistlinger; Edward A Fox; Pamela A Silver; Myles Brown
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

4.  Targeting androgen receptor in estrogen receptor-negative breast cancer.

Authors:  Min Ni; Yiwen Chen; Elgene Lim; Hallie Wimberly; Shannon T Bailey; Yuuki Imai; David L Rimm; X Shirley Liu; Myles Brown
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

5.  Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Authors:  Geneviève Deblois; Jacqueline A Hall; Marie-Claude Perry; Josée Laganière; Majid Ghahremani; Morag Park; Michael Hallett; Vincent Giguère
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

Review 6.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

Review 7.  Cistromics of hormone-dependent cancer.

Authors:  Mathieu Lupien; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2009-04-15       Impact factor: 5.678

Review 8.  Pioneer transcription factors: establishing competence for gene expression.

Authors:  Kenneth S Zaret; Jason S Carroll
Journal:  Genes Dev       Date:  2011-11-01       Impact factor: 11.361

9.  Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance.

Authors:  Mathieu Lupien; Clifford A Meyer; Shannon T Bailey; Jérôme Eeckhoute; Jennifer Cook; Thomas Westerling; Xiaoyang Zhang; Jason S Carroll; Daniel R Rhodes; X Shirley Liu; Myles Brown
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

10.  Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Andrew E Teschendorff; Kelly A Holmes; H Raza Ali; Mark J Dunning; Gordon D Brown; Ondrej Gojis; Ian O Ellis; Andrew R Green; Simak Ali; Suet-Feung Chin; Carlo Palmieri; Carlos Caldas; Jason S Carroll
Journal:  Nature       Date:  2012-01-04       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.